
ProEGCG, is a novel derivative of epigallocatechin-3-gallate (EGCG) derived from green tea. This non-hormonal supplement is designed to alleviate the menstrual discomfort and prevent endometriosis. ProEGCG enhances the bioavailability and stability of EGCG, leading to more effective therapeutic outcomes, and brings no hormonal side effect and safer to reproductive functions.
Our previous publications show that ProEGCG has stronger anti-angiogenic and anti-inflammatory properties than EGCG, making it beneficial for menstrual discomfort and endometriosis. ProEGCG demonstrates a sustainable therapeutic effect with reduced side effects on reproductive functions, as compared to current treatment.
Founded in 1963, The Chinese University of Hong Kong (CUHK) is a forward-looking comprehensive research university with a global vision and a mission to combine tradition with modernity, and to bring together China and the West. CUHK teachers and students hail from all around the world. Four Nobel laureates are associated with the university, and it is the only tertiary institution in Hong Kong with recipients of the Nobel Prize, Turing Award, Fields Medal and Veblen Prize sitting as faculty in residence. CUHK graduates are connected worldwide through an extensive alumni network. CUHK undertakes a wide range of research programmes in many subject areas, and strives to provide scope for all academic staff to undertake consultancy and collaborative projects with industry.